En Es
Categories

Industry News

Global Minimally Invasive Surgery (MIS) Market to Surpass USD 325 Billion by 2031

By HospiMedica International staff writers
22 Jun 2022

Image: The global minimally invasive surgery (MIS) market is forecasted to surpass USD 325 billion by 2031 (Photo courtesy of Pexels)

Technological advancements in robotics, image guidance systems, and equipment such as laparoscopic instruments and sutures continue to enhance the benefits of minimally invasive surgery (MIS) techniques. The adoption of laparoscopic techniques, particularly in general surgery, has been one of the key drivers of the growth in the MIS market. The surge in laparoscopic procedures performed globally over the past few decades has generated massive revenues for the market players. Medtech companies have also earned significant revenues from the sales of surgical equipment made of innovative materials, such as in handheld equipment. Moreover, a rise in the number of MIS procedures in cardiology, particularly for transcatheter aortic valve replacement (TAVR), has offered growth opportunities for the key players in the MIS market. The growing adoption of robot-assisted surgeries in multiple specialties has allowed companies to increase their share in the minimally invasive surgery market. The global MIS market is projected to surpass USD 325 billion by 2031, driven by growing patient awareness of the advantages of MIS over open surgeries, continuous innovation in surgical robots, and constant advancements in other MIS-associated technologies during the 2022-2031 forecast period.


These are the latest findings of Transparency Market Research (Albany, NY, USA), a global market intelligence company.


Continuous innovation in robotic surgery systems has contributed significantly to the growth of the MIS market. Increasing adoption of and preference for robotics-assisted surgical systems, particularly in complex surgeries, has driven the revenue growth of the market players. Over the past few years, there has been rapid commercialization of surgical robots in the MIS market due to their adoption in the fields of orthopedic and neurology. There has been increased preference for MIS among surgeons as well as patients in orthopedic procedures over the past few decades. The demand for MIS for orthopedic procedures, including knee replacement, continues to grow, thereby expanding the MIS market.


The adoption of cutting-edge 3D visualization technology and innovations in surgical instruments and sutures has opened up huge growth opportunities for the players in the MIS market. Medtech and healthcare IT companies have been increasing their R&D activities and investments in surgical instruments to capitalize on the growth in the MIS market. Growing awareness among the elderly population about the benefits of MIS such as short hospital stay and rapid post-surgery recovery is propelling the demand in the MIS market. Moreover, increased access to medical reimbursements for chronic diseases is contributing to the demand for MIS in hospitals.


Additionally, the remarkable pace of adoption of laparoscopic procedures in various specialties is driving constant advancements in MIS-associated technologies. As the application of laparoscopic instruments continues to grow in the near future, growing awareness of the advantages of surgical robots over conventional laparoscopy, and new-age instruments in the MIS market, such as the highly popular single-incision laparoscopic surgery, are likely to open up new opportunities for the market players.


Geographically, Europe held a substantial share of the global MIS market in 2020 mainly due to a rise in the region’s elderly population and is anticipated to hold a significant share of the global MIS market during the forecast period. Latin America is expected to emerge as an extremely lucrative MIS market and register a high CAGR during 2022-2031, as the high prevalence of chronic illness in the region will propel the demand for MIS.


Related Links:
Transparency Market Research 



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

27 Jun 2022
Robot-Assisted Surgical Devices Market Driven by Increased Demand for Patient-Specific Surgeries
Given the growing incidence of lifestyle diseases and demand for affordable healthcare, effective surgery using robotic devices can result in a decline in treatment costs and drive the growth of the global robot-assisted surgical devices (RASD) market.
Read More
24 Jun 2022
Fujirebio Acquires ADx NeuroSciences to Speed Development of Neurodegenerative Diseases Diagnostic Tests
Fujirebio Holdings, Inc. (Tokyo, Japan) has announced the acquisition of ADx NeuroSciences (Gent, Belgium) for EUR 40 million in a deal that is expected to close in July 2022, pending the satisfaction of customary closing conditions.
Read More
23 Jun 2022
Hospital Microbiology Testing Market Driven by Increasing Prevalence of Chronic Diseases
Rising medical expenditure as well as the presence of well-established modern healthcare infrastructure in various developed as well as developing regions is fueling the growth of the global hospital microbiology testing market.
Read More
21 Jun 2022
Medix Biochemica Acquires IVD Raw Materials Producer Bioresource Technology
Medix Biochemica (Espoo, Finland) has acquired 100% of the shares of Bioresource Technology (BRT, Weston, FL, USA) to broaden its base matrix capabilities and further strengthen its local presence in the US market.
Read More
21 Jun 2022
Global Bedside Testing Market to Witness Promising Prospects in Critical Care
Point-of-care or point-of-use diagnostics, also known as bedside testing, has gained increased prominence in analytical testing over the past few years as it provides clinically relevant information without the need for a dedicated laboratory.
Read More
20 Jun 2022
Global Sepsis Diagnostics Market Driven by Rising Hospital-Acquired Illnesses
The global sepsis diagnostics market is expected to grow at a CAGR of 8.3% during the period 2022-2028 to reach almost USD 0.88 billion by 2028, driven by a rise in the number of hospital-acquired illnesses and the rapidly growing molecular diagnostics market, although the high cost of automated diagnostic instruments could hamper market growth.
Read More
14 Jun 2022
BD Partners with Mayo Clinic Platform for Access to World's Largest Collection of Clinical Data
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA) has entered into a collaboration with Mayo Clinic Platform (Rochester, MN, USA) to access de-identified patient data from Mayo Clinic Platform_Discover.
Read More
14 Jun 2022
Quidel Partners with Global Lyme Alliance, Leads in Lyme Disease Testing
Quidel Corporation (San Diego, CA, USA) is joining forces with Global Lyme Alliance (Stamford, CT, USA) to heighten public awareness around Lyme disease during Lyme Disease Awareness Month (in May) and beyond.
Read More
09 Jun 2022
BD and Certest Collaborate on Monkeypox Molecular Diagnostic Test
Becton, Dickinson and Company (BD Franklin Lakes, NJ, USA) and CerTest Biotec (Zaragoza, Spain) have entered into a collaboration to develop a molecular diagnostic test for the Monkeypox virus.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions